Improving CRISPR-Cas9’s Rate of Homology-Directed Repair
Integrated DNA Technologies Suggests Strategies to Boost Efficiency, Avoid Blunt-End Incorporation, and Reduce Toxicity
On the Clock
Can Transcriptomics Help Find the Right Time to Administer Chemotherapy?
Commercializing Gene Therapies
Using High-Touch Services to Enhance Patient Outcomes
What the Top 10 Biopharma CEOs Are Making
Surging Markets Drive Double- and Triple-Digit Percentage Gains for Compensation
For full access to this article login to GEN Select now.
With Digital PCR, the Rare Becomes Routine
Applications Which Bring Rare Events to Light Are Proliferating
- Even standard polymerase chain reaction ( PCR ) technology should, in principle, boost weak mutant signals so that they may emerge from all the genomic noise emitted by wild-type sequences. Yet standard PCR , for all its sequence-amplifying and signal-boosting powers, is still a qualitative technique. That is, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.